OccuRx Overview
- Year Founded
-
2014

- Status
-
Acquired/Merged
- Employees
-
5

- Latest Deal Type
-
M&A
OccuRx General Information
Description
Developer of therapeutic strategies designed to aid in the treatment of disorders associated with retinal fibrosis. The company's strategies offer proprietary small-molecule drugs to address the unmet clinical need for targeted ocular therapies to enhance visual acuity and prevent vision loss in inflammatory and degenerative eye diseases, enabling healthcare professionals to prevent the growth of new and abnormal blood vessels and reduce inflammation of the neurons in the retina.
Contact Information
Website
www.occurx.comCorporate Office
- 31 Queen Street
- Level 9
- Melbourne, Victoria 3000
- Australia
Corporate Office
- 31 Queen Street
- Level 9
- Melbourne, Victoria 3000
- Australia
OccuRx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 19-Dec-2024 | Completed | Generating Revenue | |||
6. Later Stage VC | 05-Sep-2022 | Completed | Clinical Trials - Phase 2 | |||
5. Grant | 20-Jul-2022 | Completed | Clinical Trials - Phase 2 | |||
4. Later Stage VC | 01-Jan-2020 | Completed | Clinical Trials - Phase 2 | |||
3. Later Stage VC | 01-Jan-2019 | Completed | Clinical Trials - Phase 2 | |||
2. Seed Round | 19-May-2015 | $5.13M | $5.13M | Completed | Startup | |
1. Angel (individual) | Completed | Startup |
OccuRx Comparisons
Industry
Financing
Details
OccuRx Competitors (9)
One of OccuRx’s 9 competitors is Clearside Biomedical, a Formerly VC-backed company based in Alpharetta, GA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Clearside Biomedical | Formerly VC-backed | Alpharetta, GA | ||||
Adverum Biotechnologies | Formerly VC-backed | Redwood City, CA | ||||
Beacon Therapeutics | Venture Capital-Backed | Alachua, FL | ||||
Gradalis | Private Equity-Backed | Carrollton, TX | ||||
Rein Therapeutics | Formerly VC-backed | Austin, TX |
OccuRx Patents
OccuRx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4308541-A1 | Compounds for the treatment of disorders and salts and polymorphs thereof | Pending | 17-Mar-2021 | ||
CA-3213293-A1 | Compounds for the treatment of disorders and salts and polymorphs thereof | Pending | 17-Mar-2021 | ||
AU-2022238294-A1 | Compounds for the treatment of disorders and salts and polymorphs thereof | Pending | 17-Mar-2021 | ||
US-20240174598-A1 | Compounds for the treatment of disorders and salts and polymorphs thereof | Pending | 17-Mar-2021 | ||
AU-2020901858-A0 | Compounds and methods for the treatment of eye disorders | Inactive | 05-Jun-2020 |
OccuRx Signals
OccuRx Former Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Brandon Biocatalyst | Venture Capital | Minority | ||
Brandon Capital | Venture Capital | Minority | ||
Certa Therapeutics | Corporation | Minority | ||
Stoic Venture Capital | Venture Capital | Minority | ||
Uniseed | Venture Capital | Minority |
OccuRx FAQs
-
When was OccuRx founded?
OccuRx was founded in 2014.
-
Where is OccuRx headquartered?
OccuRx is headquartered in Melbourne, Australia.
-
What is the size of OccuRx?
OccuRx has 5 total employees.
-
What industry is OccuRx in?
OccuRx’s primary industry is Biotechnology.
-
Is OccuRx a private or public company?
OccuRx is a Private company.
-
What is OccuRx’s current revenue?
The current revenue for OccuRx is
. -
How much funding has OccuRx raised over time?
OccuRx has raised $15.3M.
-
Who are OccuRx’s investors?
Brandon Biocatalyst, Brandon Capital, Certa Therapeutics, Stoic Venture Capital, and Uniseed have invested in OccuRx.
-
Who are OccuRx’s competitors?
Clearside Biomedical, Adverum Biotechnologies, Beacon Therapeutics, Gradalis, and Rein Therapeutics are some of the 9 competitors of OccuRx.
-
When was OccuRx acquired?
OccuRx was acquired on 19-Dec-2024.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »